Robotic Surgical Companion Global Market Report 2025

The robotic surgical companion market size has grown rapidly in recent years. It will grow from $6.06 billion in 2024 to $6.9 billion in 2025 at a compound annual growth rate (CAGR) of 14%. The growth during the historic period can be attributed to rising investments in healthcare robotics, increasing surgeon adoption of robotic assistance, growing demand for minimally invasive surgical procedures, higher healthcare spending on advanced medical technologies, and a stronger emphasis on precision and efficiency in surgical operations.

The robotic surgical companion market size is expected to see rapid growth in the next few years. It will grow to $11.52 billion in 2029 at a compound annual growth rate (CAGR) of 13.6%. The growth during the forecast period can be attributed to the rising trend of physician-owned surgical facilities, increasing use of robotics in complex and specialty surgeries, growing patient awareness and preference for minimally invasive robotic procedures, expanding adoption of cloud-based surgical data analytics, and a stronger focus on minimizing surgical errors and complications. Key trends in the forecast period include the integration of artificial intelligence and machine learning to enhance surgical precision, advancements in haptic feedback and surgeon control systems, the adoption of cloud-based surgical data management, progress in miniaturized and flexible robotic instruments, and the incorporation of augmented reality and imaging technologies.

The increasing incidence of cancer is expected to drive the growth of the robotic surgical companion market in the coming years. Cancer is a disease characterized by the uncontrolled multiplication of abnormal cells that can invade nearby tissues and spread to other parts of the body. The rise in cancer cases is largely attributed to unhealthy lifestyle habits such as poor diet, lack of physical activity, and tobacco use, which heighten the risk of cell damage and abnormal growth. Robotic surgical companions play a crucial role in cancer treatment by enabling highly precise and minimally invasive procedures that minimize damage to healthy tissues and support faster recovery. For instance, in February 2024, the World Health Organization, a Switzerland-based intergovernmental organization, reported that the number of new cancer cases is projected to surpass 35 million by 2050, representing a 77% increase compared to approximately 20 million cases in 2022. Therefore, the growing prevalence of cancer is contributing to the expansion of the robotic surgical companion market.

Leading companies in the robotic surgical companion market are emphasizing technological advancements, particularly in AI-powered robotic surgery systems, to enhance surgical precision, reduce operating time, and improve patient outcomes. An AI-powered robotic surgery system combines artificial intelligence algorithms with robotic instruments to assist surgeons in planning, guiding, and executing procedures with greater accuracy and efficiency. For example, in July 2025, CARE Hospitals, an India-based healthcare provider, introduced the Stryker Mako Robotic System to improve precision in orthopedic surgeries. This advanced AI-based technology enables highly accurate and personalized joint replacement surgeries using detailed 3D modeling and real-time robotic assistance. Its key advantages include enhanced surgical accuracy, reduced tissue trauma, less postoperative pain, faster recovery, and more predictable outcomes. The system aims to improve the quality and consistency of orthopedic surgeries, supporting better long-term joint function with shorter hospital stays and fewer complications compared to conventional techniques.

In October 2025, Zimmer Biomet Holdings Inc., a US-based medical device company, acquired Monogram Technologies Inc. for an undisclosed amount. This acquisition aims to strengthen Zimmer Biomet’s leadership in orthopedic surgery innovation by incorporating Monogram’s AI-driven technologies to create the first fully autonomous robotic surgical solutions. The move expands Zimmer Biomet’s robotics portfolio and provides surgeons with a more comprehensive and advanced robotic ecosystem to improve surgical outcomes. Monogram Technologies Inc. is a US-based medical device company specializing in robotic surgical companions.

Major players in the robotic surgical companion market are Johnson & Johnson, Siemens Healthineers AG, Medtronic plc, Stryker Corporation, Zimmer Biomet Holdings Inc., Smith & Nephew plc, KUKA AG, Globus Medical Inc., Renishaw plc, Meere Company Inc., Asensus Surgical Inc., avateramedical GmbH, Accuray Incorporated, Distalmotion SA, Neocis Inc., Preceyes B.V., Medicaroid Corporation, NDR Medical Technology Pte. Ltd., Robocath SAS, eCential Robotics SAS, and Microbot Medical Inc.

North America was the largest region in the robotic surgical companion market in 2024. The regions covered in robotic surgical companion report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The fast surge in U.S. tariffs and the trade tensions that followed in spring 2025 are heavily affecting the medical equipment sector, particularly for imported imaging machine components, surgical-grade stainless steel, and plastic disposables. Hospitals and clinics resist price hikes, pressuring manufacturers’ margins. Regulatory hurdles compound the problem, as tariff-related supplier changes often require re-certification of devices, delaying time-to-market. Companies are mitigating risks by dual-sourcing critical parts, expanding domestic production of commoditized items, and accelerating R&D in cost-efficient materials.

The robotic surgical companion market research report is one of a series of new reports that provides robotic surgical companion market statistics, including robotic surgical companion industry global market size, regional shares, competitors with a robotic surgical companion market share, detailed robotic surgical companion market segments, market trends and opportunities, and any further data you may need to thrive in the robotic surgical companion industry. This robotic surgical companion market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

A robotic surgical companion refers to an advanced robotic system that assists surgeons during surgical procedures by offering precision, improved dexterity, and real-time guidance, which enhances surgical outcomes and minimizes procedural risks. It also simplifies complex surgical tasks, enabling minimally invasive techniques and promoting faster patient recovery.

The main components of robotic surgical companions include hardware, software, and services. Hardware consists of the physical components that form the robotic system, encompassing product types such as surgical robots, robotic surgical assistants, robotic navigation systems, and others. These systems are utilized in various applications, including general surgery, urology, gynecology, orthopedics, cardiovascular surgery, neurosurgery, and others, and are employed by end users such as hospitals, ambulatory surgical centers, specialty clinics, and others.

The countries covered in the robotic surgical companion market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The robotic surgical companion market consists of revenues earned by entities providing services such as robotic-assisted surgery, surgical planning and navigation support, real-time intraoperative guidance, system maintenance and software updates, and training and simulation for surgeons. The market value includes the value of related goods sold by the service provider or included within the service offering. The robotic surgical companion market also includes sales of robotic instrument holders, robotic endoscopic systems, and haptic feedback devices. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.